Polymer Capital Management (Us) LLC Jazz Pharmaceuticals PLC Transaction History
Polymer Capital Management (Us) LLC
- $388 Billion
- Q1 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 2,445 shares of JAZZ stock, worth $266,456. This represents 0.08% of its overall portfolio holdings.
Number of Shares
2,445Holding current value
$266,456% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding JAZZ
# of Institutions
596Shares Held
60.5MCall Options Held
424KPut Options Held
190K-
Black Rock Inc. New York, NY6.15MShares$670 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.02MShares$656 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.47MShares$269 Million0.73% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.33MShares$254 Million0.07% of portfolio
-
State Street Corp Boston, MA1.97MShares$214 Million0.01% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.83B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...